Patents by Inventor Mark Hylarides

Mark Hylarides has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High dose radionuclide complexes for bone marrow suppression
    Publication number: 20070053833
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Application
    Filed: July 12, 2006
    Publication date: March 8, 2007
    Inventors: Alan Fritzberg, Paul Abrams, Lauren Tatalick, Kent Thoelke, James Bryan, Mark Hylarides, Elizabeth John
  • High dose radionuclide complexes for bone marrow suppression
    Publication number: 20050238578
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Application
    Filed: June 30, 2004
    Publication date: October 27, 2005
    Inventors: Alan Fritzberg, Paul Abrams, Lauren Tatalick, Kent Thoelke, James Bryan, Mark Hylarides, Elizabeth John
  • High dose radionuclide complexes for bone marrow suppression
    Publication number: 20050129667
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Application
    Filed: January 24, 2005
    Publication date: June 16, 2005
    Inventors: Alan Fritzberg, Paul Abrams, Lauren Tatalick, Kent Thoelke, James Bryan, Mark Hylarides, Elizabeth John
  • Methods of use of antibodies with reduced immunogenicity or toxicity
    Publication number: 20050100545
    Abstract: Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.
    Type: Application
    Filed: July 31, 2003
    Publication date: May 12, 2005
    Applicant: NeoRx Corporation
    Inventors: Scott Graves, John Reno, Robert Mallett, Mark Hylarides
  • High dose radionuclide complexes for bone marrow suppression
    Publication number: 20050063905
    Abstract: The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
    Type: Application
    Filed: February 23, 2004
    Publication date: March 24, 2005
    Inventors: Alan Fritzberg, Paul Abrams, Lauren Tatalick, Kent Thoelke, James Bryan, Mark Hylarides, Elizabeth John
  • Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods
    Publication number: 20050008635
    Abstract: Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.
    Type: Application
    Filed: February 25, 2004
    Publication date: January 13, 2005
    Applicant: NeoRx Corporation
    Inventors: Scott Graves, John Reno, Robert Mallett, Mark Hylarides, Stephen Searle, Andrew Henry, Jan Pedersen, Anthony Rees